Select Medical Holdings Co. (NYSE:SEM) Declares Quarterly Dividend of $0.06

Select Medical Holdings Co. (NYSE:SEM) declared a quarterly dividend on Thursday, February 13th, Wall Street Journal reports. Investors of record on Monday, March 3rd will be given a dividend of 0.0625 per share by the health services provider on Thursday, March 13th. This represents a $0.25 annualized dividend and a yield of 1.37%. The ex-dividend date of this dividend is Monday, March 3rd.

Select Medical has increased its dividend by an average of 10.1% annually over the last three years. Select Medical has a dividend payout ratio of 17.9% meaning its dividend is sufficiently covered by earnings. Research analysts expect Select Medical to earn $1.41 per share next year, which means the company should continue to be able to cover its $0.25 annual dividend with an expected future payout ratio of 17.7%.

Select Medical Stock Performance

SEM stock opened at $18.19 on Friday. Select Medical has a 1-year low of $16.20 and a 1-year high of $40.98. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The stock has a 50-day moving average price of $19.06 and a 200-day moving average price of $27.48. The firm has a market cap of $2.35 billion, a PE ratio of 11.02, a price-to-earnings-growth ratio of 0.64 and a beta of 1.45.

Select Medical (NYSE:SEM) last issued its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.29 by ($0.11). The business had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.50 billion. Select Medical had a net margin of 3.23% and a return on equity of 14.04%. As a group, equities research analysts expect that Select Medical will post 1.17 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on SEM shares. Benchmark upgraded shares of Select Medical from a “hold” rating to a “buy” rating and set a $23.00 target price for the company in a research note on Monday, February 24th. UBS Group cut their target price on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, January 3rd. Royal Bank of Canada dropped their price target on Select Medical from $47.00 to $23.00 and set an “outperform” rating on the stock in a report on Monday, February 24th. Finally, StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, February 21st. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, Select Medical has an average rating of “Moderate Buy” and a consensus price target of $27.25.

Insider Transactions at Select Medical

In related news, VP Robert G. Breighner, Jr. sold 4,989 shares of the business’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the transaction, the vice president now directly owns 30,356 shares in the company, valued at $605,602.20. The trade was a 14.12 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 17.50% of the company’s stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.